To allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.
About This Bill
Committee
Latest Action · March 1, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.